What are targeted drugs?
ADC评论
August 17, 2022
Targeted drugs refer to drugs or their preparations that are endowed with targeting ability. The purpose is to enable the drug or its carrier to
Month: August 2022
FDA accepts Polivy in combination with R-CHP for DLBCL
ADC评论
August 17, 2022
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma The Food and Drug Administration (FDA)
Bayer’s three cutting-edge medical technologies
ADC评论
August 16, 2022
Major advances in science and technology are changing the way scientists study disease and have the potential to improve diagnosis and treatment in the future.
The first human-to-dog transmission of monkeypox
ADC评论
August 16, 2022
According to the British “Daily Telegraph” on the 14th, a domestic pet dog in Paris, France, was infected with the monkeypox virus after sleeping in
Tumors that can be treated with Proton therapy technology
ADC评论
August 15, 2022
Proton therapy technology is a kind of radiotherapy, and it is an internationally recognized cutting-edge technology in radiotherapy. Proton therapy belong to particle beams. Different
What is targeted drug delivery?
ADC评论
August 15, 2022
There is a big difference between targeted drugs and ordinary drugs. They can neither be taken blindly by themselves, nor can they ignore their suitability.
FDA Grants Fast Track Designation to Efzofitimod for the Treatment of Pulmonary Sarcoidosis
ADC评论
August 13, 2022
On August 11, aTyr Pharma announced that the FDA has granted Fast Track designation to Efzofitimod (ATYR1923) for the treatment of pulmonary sarcoidosis. This year,
Common Linker Types in ADC Drugs and Resection Mechanism in vivo
ADC评论
August 13, 2022
ADC drugs refer to monoclonal antibodies linked by covalent linkers and cytotoxic small molecule payloads to achieve targeted drug delivery. ADC drug targeted therapy mechanism1:
ADC transaction volume soars Big pharma has fierce competition
ADC评论
August 12, 2022
After Daiichi Sankyo detonated the market, ADC instantly became Jerusalem in the hearts of pharmaceutical companies, and pilgrims came in droves. Since the beginning of
Insilicon Received D2 Round Of Financing
ADC评论
August 12, 2022
On August 10, Insilicon, a clinical-stage drug development company driven by end-to-end artificial intelligence, announced today that it has received a D2 round of financing.
Improved CAR-T therapy promises to cure leukemia (T-ALL)
ADC评论
August 11, 2022
In a new study, researchers from St. Jude Children’s Research Hospital have improved chimeric antigen receptor (CAR) T-cell (CAR-T) therapy. Their new simplified method selects
Merck and Cerevance collaborate to explore new targets for Alzheimer’s disease
ADC评论
August 11, 2022
On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover
